- Home
- GPCR vs NVGS Comparison
GPCR vs NVGS Comparison
Compare GPCR & NVGS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GPCR
- NVGS
- Stock Information
- Founded
- GPCR 2016
- NVGS 1997
- Country
- GPCR United States
- NVGS United Kingdom
- Employees
- GPCR N/A
- NVGS N/A
- Industry
- GPCR
- NVGS Marine Transportation
- Sector
- GPCR
- NVGS Consumer Discretionary
- Exchange
- GPCR Nasdaq
- NVGS Nasdaq
- Market Cap
- GPCR 1.1B
- NVGS 994.3M
- IPO Year
- GPCR 2023
- NVGS N/A
- Fundamental
- Price
- GPCR $17.59
- NVGS $15.47
- Analyst Decision
- GPCR Strong Buy
- NVGS Strong Buy
- Analyst Count
- GPCR 7
- NVGS 2
- Target Price
- GPCR $76.17
- NVGS $22.00
- AVG Volume (30 Days)
- GPCR 734.9K
- NVGS 489.4K
- Earning Date
- GPCR 08-11-2025
- NVGS 08-12-2025
- Dividend Yield
- GPCR N/A
- NVGS 1.29%
- EPS Growth
- GPCR N/A
- NVGS 9.28
- EPS
- GPCR N/A
- NVGS 1.27
- Revenue
- GPCR N/A
- NVGS $583,931,000.00
- Revenue This Year
- GPCR N/A
- NVGS $3.28
- Revenue Next Year
- GPCR N/A
- NVGS N/A
- P/E Ratio
- GPCR N/A
- NVGS $12.43
- Revenue Growth
- GPCR N/A
- NVGS 6.38
- 52 Week Low
- GPCR $13.22
- NVGS $10.55
- 52 Week High
- GPCR $45.37
- NVGS $17.53
- Technical
- Relative Strength Index (RSI)
- GPCR 31.53
- NVGS 49.03
- Support Level
- GPCR $17.45
- NVGS $15.97
- Resistance Level
- GPCR $18.78
- NVGS $16.56
- Average True Range (ATR)
- GPCR 0.82
- NVGS 0.36
- MACD
- GPCR 0.00
- NVGS -0.08
- Stochastic Oscillator
- GPCR 5.00
- NVGS 28.16
About GPCR Structure Therapeutics Inc.
Structure Therapeutics Inc is a clinical-stage biopharmaceutical company developing novel oral small-molecule therapeutics to treat a wide range of chronic diseases with unmet medical needs. Its differentiated technology platform leverages both structure-based drug discovery and expertise in computational chemistry to discover and develop small molecule therapeutics against G-protein coupled receptors (GPCRs). The group operates and manages its business as one reportable and operating segment, which is the business of research and development of medicines that target chronic diseases with unmet medical needs.
About NVGS Navigator Holdings Ltd. (Marshall Islands)
Navigator Holdings Ltd owns and operates liquefied gas carriers, which include a fleet of handysize liquefied gas carriers. The company also owns a share in an ethylene export marine terminal at Morgan's Point, Texas on the Houston Ship Channel (the Ethylene Export Terminal) through a joint venture (the Export Terminal Joint Venture). Company play a vital role in theglobalised liquefied gas supply chain, providing gas transportation solutions for energy companies, industrial users and commodity traders.